With a proven track record in securing regulatory approval prior to patent expiries, we have obtained marketing authorisations in nearly 40 countries to date and export to most of the European Union.

Established in 1985, Medis draws on the development and manufacturing capabilities of its parent company, the Actavis Group, previously known as Pharmaco. Medis handles sales of products and intellectual property in the form of registration dossiers for the Group.

Our pharmaceutical knowledge and expertise have contributed significantly to the Actavis Group’s expansion in international markets. In turn, the combined strengths of companies within the Group enable Medis to extend its portfolio and improve its services still further.

Medis has experienced rapid growth over recent years. Our Business Development teams market intellectual property and pharmaceutical products in international markets. For customer service, including the receipt and processing of orders or related matters, please contact our head office in Iceland.

For any further information please take a look at our web site: www.medis.is